What is Pixel Optics?
Headquartered in Roanoke, Virginia, Pixel Optics operates at the intersection of advanced healthcare services and medical technology. With a workforce of 20 to 49 professionals and annual revenues ranging between 5M and 10M, the company has established itself as a specialized player in the healthcare sector. Its core business model focuses on the development and commercialization of innovative optical and medical solutions, designed to address critical gaps in patient care. The company's ability to attract high-caliber institutional backing underscores its technical viability and potential for long-term market disruption.
How much funding has Pixel Optics raised?
Pixel Optics has raised a total of $107.2M across 5 funding rounds:
Series A
$8.4M
Series B
$23.8M
Series C
$30M
Debt
$10M
Private Equity
$35M
Series A (2006): $8.4M with participation from Delphi Ventures and The Carlyle Group
Series B (2008): $23.8M led by Delphi Ventures and The Carlyle Group
Series C (2008): $30M supported by Longitude Capital Will
Debt (2011): $10M featuring Horizon Technology Finance
Private Equity (2011): $35M backed by Safeguard Scientifics, Stark Investments, The Carlyle Group, Longitude Capital, and Delphi Ventures
Key Investors in Pixel Optics
Longitude Capital
Longitude Capital is a healthcare focused venture capital firm that invests in biotechnology, medical technology and health solutions companies, pairing sector expertise, flexible capital and active partnership to help innovators scale and improve patient care.
The Carlyle Group
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America, managing numerous funds focused on buyouts, venture and growth capital.
Safeguard Scientifics
Safeguard Scientifics is a venture capital and private equity company that provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media.
What's next for Pixel Optics?
With the infusion of $10M, Pixel Optics is well-positioned to accelerate its commercialization efforts and expand its footprint in the healthcare services market. The strategic deployment of this capital will likely focus on scaling production capabilities, enhancing research and development initiatives, and strengthening its competitive moat against established industry incumbents. As the company transitions into its next phase of growth, the focus will shift toward optimizing operational efficiencies and exploring potential exit strategies or further market penetration, supported by the deep sector expertise of its long-term investment partners.
See full Pixel Optics company page
